1. Home
  2. JFU vs TENX Comparison

JFU vs TENX Comparison

Compare JFU & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 9F Inc.

JFU

9F Inc.

N/A

Current Price

$3.88

Market Cap

54.5M

Sector

Finance

ML Signal

N/A

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$13.59

Market Cap

56.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JFU
TENX
Founded
2006
1967
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.5M
56.2M
IPO Year
2018
2001

Fundamental Metrics

Financial Performance
Metric
JFU
TENX
Price
$3.88
$13.59
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$29.67
AVG Volume (30 Days)
2.0K
360.6K
Earning Date
12-09-2022
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$4.64
52 Week High
$9.48
$18.38

Technical Indicators

Market Signals
Indicator
JFU
TENX
Relative Strength Index (RSI) 34.98 49.08
Support Level $1.39 $12.20
Resistance Level $4.91 $14.15
Average True Range (ATR) 0.18 1.25
MACD -0.04 0.08
Stochastic Oscillator 0.36 47.60

Price Performance

Historical Comparison
JFU
TENX

About JFU 9F Inc.

9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: